Clinical trial
PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer
NCT00055705 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00055705 |
|---|---|
| Title | PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer |
| Official title | A Phase I Clinical Trial To Assess The Safety And Efficacy Of Intraperitoneal PV701 Administrations In Patients With Advanced Or Recurrent Malignancy Largely Confined To The Peritoneal Cavity |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Biological |
| Interventions | PV701 |
| Start date | Jan 1, 2003 |
| First posted | Mar 7, 2003 |
| Last update posted | Apr 26, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: